London, United Kingdom

Keith Bowers

This inventor holds 1 USPTO granted patent. Top assignee: Medimmune Limited. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Bowers. Retrieved from https://idiyas.com/inventor/keith-bowers

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Keith Bowers

Introduction

Keith Bowers is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His work focuses on creating binding members that target specific complexes, which can have important implications for medical treatments.

Latest Patents

Keith Bowers holds a patent for "Antibodies specific for the complex of interleukin-6 and the interleukin-6 receptor." This patent describes binding members, especially antibody molecules that bind the IL-6:IL-6Ra complex formed by IL-6 and IL-6Ra. These binding members are designed to have greater specificity for inhibiting the pathological effects of IL-6 rather than its beneficial effects, compared to binding members that interact with IL-6 or IL-6Ra outside the complex. He has 1 patent to his name.

Career Highlights

Bowers is currently associated with Medimmune Limited, where he continues to innovate in the field of antibody development. His work has the potential to advance therapeutic strategies for various diseases linked to interleukin-6.

Collaborations

Throughout his career, Keith has collaborated with notable colleagues, including Philip Mallinder and Steven Godfrey Lane. These collaborations have likely contributed to the success of his research and patent developments.

Conclusion

Keith Bowers is a distinguished inventor whose work in antibody development is paving the way for new medical treatments. His innovative approach to targeting specific complexes demonstrates the importance of precision in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…